Predicting complication risks after sleeve lobectomy for non-small cell lung cancer.

IF 4 2区 医学 Q2 ONCOLOGY Translational lung cancer research Pub Date : 2024-06-30 Epub Date: 2024-06-27 DOI:10.21037/tlcr-24-325
Yiming He, Lin Huang, Jiajun Deng, Yifan Zhong, Tao Chen, Yunlang She, Lei Jiang, Deping Zhao, Dong Xie, Gening Jiang, Stefano Bongiolatti, Mara B Antonoff, René Horsleben Petersen, Chang Chen
{"title":"Predicting complication risks after sleeve lobectomy for non-small cell lung cancer.","authors":"Yiming He, Lin Huang, Jiajun Deng, Yifan Zhong, Tao Chen, Yunlang She, Lei Jiang, Deping Zhao, Dong Xie, Gening Jiang, Stefano Bongiolatti, Mara B Antonoff, René Horsleben Petersen, Chang Chen","doi":"10.21037/tlcr-24-325","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sleeve lobectomy is a challenging procedure with a high risk of postoperative complications. To facilitate surgical decision-making and optimize perioperative treatment, we developed risk stratification models to quantify the probability of postoperative complications after sleeve lobectomy.</p><p><strong>Methods: </strong>We retrospectively analyzed the clinical features of 691 non-small cell lung cancer (NSCLC) patients who underwent sleeve lobectomy between July 2016 and December 2019. Logistic regression models were trained and validated in the cohort to predict overall complications, major complications, and specific minor complications. The impact of specific complications in prognostic stratification was explored via the Kaplan-Meier method.</p><p><strong>Results: </strong>Of 691 included patients, 232 (33.5%) developed complications, including 35 (5.1%) and 197 (28.5%) patients with major and minor complications, respectively. The models showed robust discrimination, yielding an area under the receiver operating characteristic (ROC) curve (AUC) of 0.853 [95% confidence interval (CI): 0.705-0.885] for predicting overall postoperative complication risk and 0.751 (95% CI: 0.727-0.762) specifically for major complication risks. Models predicting minor complications also achieved good performance, with AUCs ranging from 0.78 to 0.89. Survival analyses revealed a significant association between postoperative complications and poor prognosis.</p><p><strong>Conclusions: </strong>Risk stratification models could accurately predict the probability and severity of complications in NSCLC patients following sleeve lobectomy, which may inform clinical decision-making for future patients.</p>","PeriodicalId":23271,"journal":{"name":"Translational lung cancer research","volume":null,"pages":null},"PeriodicalIF":4.0000,"publicationDate":"2024-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11225058/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational lung cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tlcr-24-325","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/27 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Sleeve lobectomy is a challenging procedure with a high risk of postoperative complications. To facilitate surgical decision-making and optimize perioperative treatment, we developed risk stratification models to quantify the probability of postoperative complications after sleeve lobectomy.

Methods: We retrospectively analyzed the clinical features of 691 non-small cell lung cancer (NSCLC) patients who underwent sleeve lobectomy between July 2016 and December 2019. Logistic regression models were trained and validated in the cohort to predict overall complications, major complications, and specific minor complications. The impact of specific complications in prognostic stratification was explored via the Kaplan-Meier method.

Results: Of 691 included patients, 232 (33.5%) developed complications, including 35 (5.1%) and 197 (28.5%) patients with major and minor complications, respectively. The models showed robust discrimination, yielding an area under the receiver operating characteristic (ROC) curve (AUC) of 0.853 [95% confidence interval (CI): 0.705-0.885] for predicting overall postoperative complication risk and 0.751 (95% CI: 0.727-0.762) specifically for major complication risks. Models predicting minor complications also achieved good performance, with AUCs ranging from 0.78 to 0.89. Survival analyses revealed a significant association between postoperative complications and poor prognosis.

Conclusions: Risk stratification models could accurately predict the probability and severity of complications in NSCLC patients following sleeve lobectomy, which may inform clinical decision-making for future patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
预测非小细胞肺癌袖状肺叶切除术后的并发症风险。
背景:袖带肺叶切除术是一种具有挑战性的手术,术后并发症风险很高。为了便于手术决策和优化围手术期治疗,我们建立了风险分层模型,以量化袖带肺叶切除术后并发症的概率:我们回顾性分析了2016年7月至2019年12月期间接受袖状肺叶切除术的691名非小细胞肺癌(NSCLC)患者的临床特征。在队列中训练并验证了逻辑回归模型,以预测总体并发症、主要并发症和特定的轻微并发症。通过 Kaplan-Meier 方法探讨了特定并发症对预后分层的影响:结果:在纳入的 691 例患者中,有 232 例(33.5%)出现并发症,其中主要并发症和次要并发症患者分别为 35 例(5.1%)和 197 例(28.5%)。这些模型显示出很强的辨别能力,预测总体术后并发症风险的接收者操作特征曲线下面积(AUC)为 0.853 [95% 置信区间 (CI):0.705-0.885],预测主要并发症风险的接收者操作特征曲线下面积(AUC)为 0.751 (95% CI:0.727-0.762)。预测轻微并发症的模型也有很好的表现,AUC 在 0.78 到 0.89 之间。生存分析显示,术后并发症与预后不良之间存在显著关联:风险分层模型可以准确预测袖带肺叶切除术后NSCLC患者出现并发症的概率和严重程度,为今后患者的临床决策提供参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.20
自引率
2.50%
发文量
137
期刊介绍: Translational Lung Cancer Research(TLCR, Transl Lung Cancer Res, Print ISSN 2218-6751; Online ISSN 2226-4477) is an international, peer-reviewed, open-access journal, which was founded in March 2012. TLCR is indexed by PubMed/PubMed Central and the Chemical Abstracts Service (CAS) Databases. It is published quarterly the first year, and published bimonthly since February 2013. It provides practical up-to-date information on prevention, early detection, diagnosis, and treatment of lung cancer. Specific areas of its interest include, but not limited to, multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer.
期刊最新文献
LungPath: artificial intelligence-driven histologic pattern recognition for improved diagnosis of early-stage invasive lung adenocarcinoma. A nomogram predicting the risk of extrathoracic metastasis at initial diagnosis of T≤3cmN0 lung cancer. Are PD-1T TILs merely an expensive and unuseful whim as biomarker? Assessing the transportability of radiomic models for lung cancer diagnosis: commercial vs. open-source feature extractors. Breaking barriers: patient-derived xenograft (PDX) models in lung cancer drug development-are we close to the finish line?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1